4.7 Review

Future insights of pharmacological prevention for AKI post cardiopulmonary bypass surgery (based on PK/PD approach)

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Efficacy of N-acetylcysteine in Preventing Acute Kidney Injury and Major Adverse Cardiac Events After Cardiac Surgery: A Meta-Analysis and Trial Sequential Analysis

Jingtao Zhao et al.

Summary: This meta-analysis and trial sequential analysis evaluated the efficacy of N-acetylcysteine (NAC) in preventing adverse events after cardiac surgery. The results showed that intravenous administration of NAC can reduce the incidence of acute kidney injury (AKI) and arrhythmia, but has no significant effect on mortality, acute myocardial infarction (AMI), cardiac insufficiency, and the use of renal replacement therapy. Oral NAC does not significantly affect the outcomes of patients after cardiac surgery.

FRONTIERS IN MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

N-Acetylcysteine's Renoprotective Effect in Cardiac Surgery: A Systematic Review and Meta-Analysis

Ying Kiat Tan et al.

Summary: This meta-analysis suggests that N-acetylcysteine (NAC) does not have a significant effect in reducing the incidence of acute kidney injury (AKI) in adult cardiac surgery patients. However, there is heterogeneity among the included studies. Further research should focus on the dosage and duration of administration for better understanding of the effect of NAC.

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Incidence and impact of silent brain lesions after coronary artery bypass grafting

Hitoshi Tachibana et al.

Summary: This study investigated the occurrence rate and factors influencing silent brain lesions following coronary artery bypass grafting (CABG), finding an incidence of 20.1%. Patients undergoing on-pump CABG and those with aortic clamping had a significantly higher rate of brain lesions. The presence of new brain lesions was associated with postoperative cognitive dysfunction (POCD).

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Article Surgery

Risk factor for acute kidney injury in patients with chronic kidney disease receiving valve surgery with cardiopulmonary bypass

Hsun-Yi Fu et al.

Summary: This study found a high incidence of postoperative AKI in patients with pre-existing impaired renal function, which was associated with high preoperative serum creatinine levels and decreased CPB target temperature. AKI patients had higher hospital mortality and a worse two-year renal function evolution compared to non-AKI patients.

ASIAN JOURNAL OF SURGERY (2021)

Article Anesthesiology

Incidence of acute kidney injury post cardiac surgery: a comparison of the AKIN and KDIGO criteria

Tiago Furquim da Silva et al.

Summary: The study found a high incidence of AKI in patients undergoing cardiac surgery, and suggested that AKI may be underdiagnosed if serum creatinine concentration is solely used as the defining criterion.

BRAZILIAN JOURNAL OF ANESTHESIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial

Heyman Luckraz et al.

Summary: The study demonstrated that the use of the RG system significantly reduced the incidence of AKI in cardiac surgical patients requiring CPB, and can be used safely and reproducibly. Larger studies are needed to confirm cost benefits.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2021)

Review Pharmacology & Pharmacy

The mechanism of action of N-acetylcysteine (NAC): The emerging role of H2S and sulfane sulfur species

Brandan Pedre et al.

Summary: Originally used as a mucolytic, N-acetylcysteine (NAC) is now a standard treatment for paracetamol poisoning and a widely used antioxidant. In addition to its traditional mechanisms, a newly discovered mechanism involves the conversion of NAC into hydrogen sulfide and sulfane sulfur species, which may explain many of its effects.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Medicine, General & Internal

Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI

Marlies Ostermann et al.

Summary: Acute kidney injury (AKI) is common after cardiac surgery and there are currently no specific pharmacological therapies, prevention and management strategies include preoperative withdrawal of certain drugs and avoidance of nephrotoxic agents, intraoperative goal-directed therapy and use of biocompatible coatings in circuits, postoperative management should follow current KDIGO AKI recommendations.

JOURNAL OF CLINICAL MEDICINE (2021)

Editorial Material Critical Care Medicine

Is nitric oxide the forgotten nephroprotective treatment during cardiac surgery?

Mina Khorashadi et al.

ANNALS OF INTENSIVE CARE (2020)

Review Biochemistry & Molecular Biology

Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury

Annalisa Noce et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2019)

Review Physiology

Loop Diuretics in Acute Kidney Injury Prevention, Therapy, and Risk Stratification

Daniel Patschan et al.

KIDNEY & BLOOD PRESSURE RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Renal Disease Is Associated With Poor Outcomes Following Isolated Coronary Artery Bypass Grafting

Mohammed J. Alramadan et al.

GLOBAL HEART (2019)

Review Pediatrics

Cardiopulmonary Bypass and AKI: AKI Is Bad, So Let's Get Beyond the Diagnosis

Catherine D. Krawczeski

FRONTIERS IN PEDIATRICS (2019)

Article Cardiac & Cardiovascular Systems

RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study

Hiromasa Katoh et al.

CARDIOVASCULAR INTERVENTION AND THERAPEUTICS (2019)

Article Critical Care Medicine

Nitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery

Chong Lei et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Chemistry, Medicinal

High-Precision Control of Plasma Drug Levels Using Feedback-Controlled Dosing

Netzahualcoyotl Arroyo-Curras et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2018)

Article Critical Care Medicine

Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis

Michael A. Gillies et al.

CRITICAL CARE (2015)

Review Biochemistry & Molecular Biology

The chemistry and biological activities of N-acetylcysteine

Yuval Samuni et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)

Review Anesthesiology

Benefits and risks of furosemide in acute kidney injury

K. M. Ho et al.

ANAESTHESIA (2010)

Article Cardiac & Cardiovascular Systems

The Effect of Various Fenoldopam Doses on Renal Perfusion in Patients Undergoing Cardiac Surgery

Massimo Meco et al.

ANNALS OF THORACIC SURGERY (2010)

Article Urology & Nephrology

Multiple-Dose Pharmacokinetics and Pharmacodynamics of N-Acetylcysteine in Patients with End-Stage Renal Disease

Thomas D. Nolin et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Review Critical Care Medicine

Acute kidney injury in elderly intensive care patients: a review

Alexandra Chronopoulos et al.

INTENSIVE CARE MEDICINE (2010)

Article Urology & Nephrology

A clinical score to predict acute renal failure after cardiac surgery

CV Thakar et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)

Article Urology & Nephrology

Acute renal failure following massive mannitol infusion

AJ Pérez-Pérez et al.

AMERICAN JOURNAL OF NEPHROLOGY (2002)

Review Medicine, General & Internal

Drug therapy - Fenoldopam - A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension

MB Murphy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)